Terms: = Skin cancer AND PBRM1, BAF180, 55193, PB1, MGC156156, MGC156155
12 results:
1. The immune response-related genomic alterations in patients with malignant melanoma.
Li L; Xiang T; Li X
Medicine (Baltimore); 2024 Apr; 103(17):e37966. PubMed ID: 38669390
[TBL] [Abstract] [Full Text] [Related]
2. Multi-omics integration identifies cell-state-specific repression by pbrm1-PIAS1 cooperation.
Ho PJ; Kweon J; Blumensaadt LA; Neely AE; Kalika E; Leon DB; Oh S; Stringer CWP; Lloyd SM; Ren Z; Bao X
Cell Genom; 2024 Jan; 4(1):100471. PubMed ID: 38190100
[TBL] [Abstract] [Full Text] [Related]
3. ARID2 Deficiency Correlates with the Response to Immune Checkpoint Blockade in Melanoma.
Fukumoto T; Lin J; Fatkhutdinov N; Liu P; Somasundaram R; Herlyn M; Zhang R; Nishigori C
J Invest Dermatol; 2021 Jun; 141(6):1564-1572.e4. PubMed ID: 33333124
[TBL] [Abstract] [Full Text] [Related]
4. Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanoma.
Alkallas R; Lajoie M; Moldoveanu D; Hoang KV; Lefrançois P; Lingrand M; Ahanfeshar-Adams M; Watters K; Spatz A; Zippin JH; Najafabadi HS; Watson IR
Nat Cancer; 2020 Jun; 1(6):635-652. PubMed ID: 35121978
[TBL] [Abstract] [Full Text] [Related]
5. Lotus seed skin proanthocyanidin extract exhibits potent antioxidant property via activation of the Nrf2-ARE pathway.
Li T; Li Q; Wu W; Li Y; Hou DX; Xu H; Zheng B; Zeng S; Shan Y; Lu X; Deng F; Qin S
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):31-40. PubMed ID: 30544155
[TBL] [Abstract] [Full Text] [Related]
6. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.
Pan D; Kobayashi A; Jiang P; Ferrari de Andrade L; Tay RE; Luoma AM; Tsoucas D; Qiu X; Lim K; Rao P; Long HW; Yuan GC; Doench J; Brown M; Liu XS; Wucherpfennig KW
Science; 2018 Feb; 359(6377):770-775. PubMed ID: 29301958
[TBL] [Abstract] [Full Text] [Related]
7. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
[TBL] [Abstract] [Full Text] [Related]
8. Genomic copy number alterations of primary and secondary metastasizing pleomorphic adenomas.
Mariano FV; Gondak Rde O; Martins AS; Coletta RD; Paes de Almeida O; Kowalski LP; Krepischi AC; Altemani A
Histopathology; 2015 Sep; 67(3):410-5. PubMed ID: 25600428
[TBL] [Abstract] [Full Text] [Related]
9. SWI/SNF chromatin remodeling complexes and cancer.
Biegel JA; Busse TM; Weissman BE
Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):350-66. PubMed ID: 25169151
[TBL] [Abstract] [Full Text] [Related]
10. BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene.
Saladi SV; Wong PG; Trivedi AR; Marathe HG; Keenen B; Aras S; Liew ZQ; Setaluri V; de la Serna IL
Pigment Cell Melanoma Res; 2013 May; 26(3):377-91. PubMed ID: 23480510
[TBL] [Abstract] [Full Text] [Related]
11. The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines.
Baśkiewicz-Masiuk M; Walczak M; Grzegrzółka R; Rogowska D; Machaliński B
Arch Dermatol Res; 2006 Apr; 297(10):450-8. PubMed ID: 16502315
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder.
Wasik MA; Seldin DC; Butmarc JR; Gertz R; Marti R; Maslinski W; Kadin ME
Leuk Lymphoma; 1996 Sep; 23(1-2):125-36. PubMed ID: 9021695
[TBL] [Abstract] [Full Text] [Related]
